×
More Charts Below
Teligent Income from Continuous Operations 2010-2021 | TLGT
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Teligent income from continuous operations from 2010 to 2021. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Historical Chart (TTM)
Quarterly
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$15.5B
Dr Reddy's Laboratories (RDY)
$11.4B
BridgeBio Pharma (BBIO)
$6.4B
Bausch Health Cos (BHC)
$1.9B
Supernus Pharmaceuticals (SUPN)
$1.7B
Amphastar Pharmaceuticals (AMPH)
$1.1B
Personalis (PSNL)
$282M
Taysha Gene Therapies (TSHA)
$254M
Assembly Biosciences (ASMB)
$75M
Sol-Gel Technologies (SLGL)
$15M
Evoke Pharma (EVOK)
$3M